Omzo vs Start Willow: Compounded Semaglutide Plans Compared
Quick verdict: Omzo vs Start Willow
Omzo vs Start Willow: Omzo emphasizes clinician-guided plans with compounded semaglutide starting at $179, while Start Willow operates a direct-pay model for compounded semaglutide from $249 per month with a $299 ongoing rate and faster guaranteed shipping. Early verdict: choose Omzo if you prioritize clinician-reviewed, personalized compounding options and lower starting price; choose Start Willow if you need no-insurance access and a 3-day delivery guarantee.
Explore Omzo clinician-guided plans
Side-by-side summary for Omzo vs Start Willow
This comparison focuses on five key differences: price and billing model, clinician involvement and personalization, shipping speed and delivery policy, whether insurance or membership is required, and regulatory status of compounded medications. All statements below reflect provider materials and captured landing-page evidence.
Comparison table: core criteria
| Criteria | Omzo | Start Willow |
|---|---|---|
| Starting price | Semaglutide starting at $179 | From $249 per month; $299/month ongoing |
| Billing model | Compounded medication program, fees include medication costs | Direct-pay, no insurance, no membership fees |
| Clinician involvement | Clinician-guided plans reviewed by licensed U.S. providers; providers determine prescriptions | Prescribed by a doctor after online review; personalized plan with Willow physician |
| Shipping speed | Fast, discreet delivery (details captured on landing page) | Delivery guaranteed in 3 days or less; same day prescriptions and free 2-day shipping noted |
| Insurance / membership | FSA & HSA eligible mentioned; provider does not sell branded meds directly | No insurance required; no membership fees |
| Regulatory note | Compounded medications are not FDA-approved and have not been reviewed by the FDA | Compounded semaglutide is not FDA-approved and not reviewed by FDA; prepared by state-licensed compounding pharmacies |
Price and billing: lower starting cost vs transparent monthly pricing
Price is one of the clearest differences in Omzo vs Start Willow. Omzo advertises compounded semaglutide starting at $179 and notes tirzepatide starting at $279. Start Willow lists semaglutide from $249 for the first month with an ongoing $299/month rate. Start Willow explicitly frames its plan as direct-pay with no membership fees, while Omzo emphasizes that medication costs are included in fees collected and that branded medications would require separate pharmacy fills and costs.
See Omzo pricing and medication options
Clinician guidance and personalization
Both providers rely on clinician review, but the emphasis differs. Omzo highlights clinician-guided plans reviewed by licensed U.S. providers and that providers make the final determination about prescriptions. Start Willow also prescribes after an online clinician review and describes semaglutide as customized in collaboration with a Willow doctor as part of an individualized plan. The distinction is that Omzo repeatedly frames its model as clinician-guided and includes the option for either compounded medication or prescriptions for branded drugs to be filled separately.
Shipping and speed: guaranteed delivery vs fast discreet shipping
Shipping commitments differ in specificity. Start Willow guarantees delivery in 3 days or less and advertises same day prescriptions and free 2-day shipping. Omzo states fast, discreet delivery in its captured landing-page evidence but does not supply a specific guaranteed window in the provided materials. If rapid guaranteed shipping is critical, Start Willow is explicit about the 3-day commitment.
Check Start Willow shipping and timing
Insurance and membership considerations
Start Willow positions itself for patients who want to avoid insurance and prior authorization, stating no insurance is needed and no membership fees are charged. Omzo notes that branded medications may require filling at a pharmacy and associated costs, and mentions FSA and HSA eligibility for its plans. For people who have faced insurance denials, Start Willow highlights its direct-pay model as an intentional advantage.
Learn about Start Willow direct-pay access
Regulatory and safety notes to compare
Both providers state that their compounded medications are not FDA-approved and that the FDA does not review compounded medications for safety, effectiveness, or quality. Omzo notes compounded drugs are prepared by a state-licensed sterile compounding pharmacy and that providers determine eligibility subject to review. Start Willow notes compounding pharmacies operate under state board of pharmacy oversight and are required to meet USP standards. Neither provider’s materials supplied in this comparison include independent clinical outcomes or guarantees of weight-loss results.
Choose based on what matters most
- Choose Omzo if you want clinician-guided, personalized plans with compounded semaglutide starting at $179 and options that may include prescriptions for branded medications to be filled separately.
- Choose Start Willow if you need a direct-pay, no-insurance model with guaranteed 3-day delivery and predictable monthly billing starting from $249 and rising to $299/month ongoing.
Primary comparison summary: Omzo vs Start Willow differ most on starting price and billing model, the way clinicians guide prescriptions, shipping guarantees, and how each frames insurance and membership requirements. Use the details above to match a provider to your priorities.